Transcripts Olema Pharmaceuticals, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/07/2026			Varia. 5j.	Varia. 1 janv.
12,64 ^USD	+4,64 %		+10,97 %	-49,44 %

10/06	Transcript : Olema Pharmaceuticals, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03:20 PM
26/05	Olema Pharmaceuticals, Inc. et Bayer AG annoncent un accord de collaboration clinique et d'approvisionnement pour évaluer l'OP-3136 en association avec NUBEQA (darolutamide) dans le cancer de la prostate métastatique résistant à la castration	CI

10/06	Transcript : Olema Pharmaceuticals, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03:20 PM
23/02	Transcript : Olema Pharmaceuticals, Inc. Presents at Citi?s 2026 Virtual Oncology Leadership Summit, Feb-19-2026 01:00 PM
13/02	Transcript : Olema Pharmaceuticals, Inc. Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026, Feb-11-2026 10:00 AM
15/01	Transcript : Olema Pharmaceuticals, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 11:15 AM
15/01/25	Transcript : Olema Pharmaceuticals, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 03:45 PM
29/11/23	Transcript : Olema Pharmaceuticals, Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-29-2023 01:20 PM